Buhisan, Baby Girl .

HRN: 23-83-79  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2023
AMPICILLIN 250MG (VIAL)
10/12/2023
10/19/2023
IV
110 Mg
Every 12 Hours
Preterm, PSNB
Waiting Final Action 
10/12/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
10/12/2023
10/19/2023
IV
11 Mg
Every 24 Hours
Preterm, PSNB
Waiting Final Action 
10/16/2023
CEFTAZIDIME 1GM (VIAL)
10/16/2023
10/22/2023
IVT
110mg
Q12
Psnb, Preterm
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: